Surmodics (SRDX)
(Delayed Data from NSDQ)
$41.95 USD
-0.05 (-0.12%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $41.95 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth B Momentum F VGM
Revenue - Line of Business Segments | YR Estimate | 09/30/2023 | 09/30/2022 | 09/30/2021 | 09/30/2020 | 09/30/2019 |
---|---|---|---|---|---|---|
Revenue: In Vitro Diagnostics [$M... |
-- | 27 | 28 | 27 | 23 | 22 |
Revenue: Product sales [$M] |
-- | 61 | 55 | 46 | 44 | 40 |
Revenue: Royalties and license fe... |
-- | 62 | 36 | 47 | 41 | 48 |
Revenue: Research, development an... |
-- | 10 | 9 | 12 | 10 | 11 |
Revenue: Medical Device: Product ... |
-- | 34 | 28 | 22 | -- | -- |
Revenue: Medical Device: Royaltie... |
-- | 33 | 31 | 31 | -- | -- |
Revenue: Medical Device: License ... |
-- | 30 | 6 | 16 | -- | -- |
Revenue: Medical Device: R&D and ... |
-- | 9 | 8 | 9 | -- | -- |
Revenue: Medical Device [$M] |
-- | 106 | 72 | 78 | 71 | 78 |
Revenue: In Vitro Diagnostics: Pr... |
-- | 26 | 27 | 25 | -- | -- |
Revenue: In Vitro Diagnostics: R&... |
-- | 0 | 1 | 2 | -- | -- |
Income - Line of Business | YR Estimate | 09/30/2023 | 09/30/2022 | 09/30/2021 | 09/30/2020 | 09/30/2019 |
Operating income (loss): Medical ... |
-- | 5 | -23 | 5 | -- | -- |
Operating income (loss): In Vitro... |
-- | 13 | 13 | 14 | -- | -- |
Operating income (loss): Corporat... |
-- | -13 | -12 | -12 | -- | -- |